Jingnan An
Impact in
-
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Galectins and Cancer Biology
Papers in
-
- Advanced biosensing and bioanalysis techniques 3
- RNA Interference and Gene Delivery 2
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Yang Xu (8 shared papers)Wenxing Gu (5 shared papers)Zhiyuan Zhong (5 shared papers)Fenghua Meng (2 shared papers)Na Yu (2 shared papers)Cuiping Liu (6 shared papers)Hao Meng (1 shared paper)Jeroen J. L. M. Cornelissen (1 shared paper)
In The Last Decade
Jingnan An
21 papers receiving 289 citations
Peers
Comparison fields: 5 of 66
- Hematology 48
- Immunology 75
- Biomaterials 43
- Oncology 52
- Molecular Biology 106
Countries citing papers authored by Jingnan An
This map shows the geographic impact of Jingnan An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingnan An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingnan An more than expected).
Fields of papers citing papers by Jingnan An
This network shows the impact of papers produced by Jingnan An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingnan An. The network helps show where Jingnan An may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingnan An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 67 | |
| 2 | 2018 | 30 | |
| 3 | 2023 | 27 | |
| 4 | 2016 | 27 | |
| 5 | 2022 | 17 | |
| 6 | 2016 | 16 | |
| 7 | 2022 | 15 | |
| 8 | 2023 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2016 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Jingnan An
Jingnan An is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Biomaterials, having authored 22 papers that have together received 289 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), T-cell and B-cell Immunology (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), RNA Interference and Gene Delivery (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Immunotherapy and Immune Responses (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (48 citations), Immunology (75 citations), Biomaterials (43 citations), Oncology (52 citations) and Molecular Biology (106 citations). Jingnan An has collaborated with scholars based in China, Singapore and Germany. Frequent co-authors include Yang Xu, Wenxing Gu, Zhiyuan Zhong, Fenghua Meng, Na Yu, Cuiping Liu, Hao Meng, Jeroen J. L. M. Cornelissen, Yinan Zhong and Xiaohan Hu. Their work appears in journals such as Advanced Materials, International Immunopharmacology, Frontiers in Oncology, Bioactive Materials and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.